Bionexus Gene Lab Corp. Agrees To Invest RM 1.2 Million In Ascension Innovation (AISB) To Advance Digital Health Innovation Through Ai Adoption In Healthcare

KUALA LUMPUR, Malaysia, April 19 (Bernama-GLOBE NEWSWIRE) — BioNexus Gene Lab Corporation (NASDAQ: BGLC), a global leader in genomic diagnostics and healthcare technology, announces a strategic investment by its wholly owned subsidiary, MRNA Scientific Sdn Bhd, in Ascension Innovation Sdn Bhd (AISB), a privately held Malaysian company. This investment underscores BGLC’s commitment to advancing healthcare solutions through cutting-edge AI and predictive analytics.

Background:

http://mrem.bernama.com/viewsm.php?idm=48420

administrator

Related Articles